Stay updated on ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial
Sign up to get notified when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.

Latest updates to the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page
- Check2 days agoChange DetectedThe page now presents the ACI-24 vaccine study record for adults with Down syndrome, including its design, eligibility criteria, outcomes, and published results. It also includes participant data-sharing information and study documents.SummaryDifference61%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check16 days agoChange DetectedA banner announces NIH’s transition-related updates and says that “Super Intelligence” may be used in place of “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check23 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check30 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 on the page displaying a 403 error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the study details with a generic site error page. The page displays a standard header and footer instead of the study content.SummaryDifference20%

Stay in the know with updates to ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.